This paper is a systematic review and meta-analysis published in the Journal of Stroke concerning lipoprotein(a) and its relationship to stroke outcomes. The authors investigated the association of elevated lipoprotein(a) levels with stroke recurrence and functional outcomes in patients who have experienced ischemic stroke or transient ischemic attack. The study synthesized data from multiple studies, comprising over 17,900 patients, to conclude that higher lipoprotein(a) levels are significantly linked to increased stroke recurrence and poorer functional recovery. The research highlights lipoprotein(a) as a potential biomarker and therapeutic target for preventing subsequent strokes.